Cargando…
Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
BACKGROUND: Approximately 25% of kidney transplant recipients develop de novo anti-HLA donor-specific antibodies (dnDSA) leading to acute antibody-mediated rejection (ABMR) in 30% of patients. Preemptive therapeutic strategies are not available. METHODS: We conducted a prospective observational stud...
Autores principales: | Matignon, Marie, Pilon, Caroline, Commereuc, Morgane, Grondin, Cynthia, Leibler, Claire, Kofman, Tomek, Audard, Vincent, Cohen, José, Canoui-Poitrine, Florence, Grimbert, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487035/ https://www.ncbi.nlm.nih.gov/pubmed/28654684 http://dx.doi.org/10.1371/journal.pone.0178572 |
Ejemplares similares
-
Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
por: Pilon, Caroline, et al.
Publicado: (2020) -
Creatinine clearance after cimetidine administration in a new short procedure: comparison with plasma and renal clearances of iohexol
por: Stehlé, Thomas, et al.
Publicado: (2019) -
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study
por: Morel, Antoine, et al.
Publicado: (2021) -
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring
por: Leibler, Claire, et al.
Publicado: (2018) -
Successful Treatment of Lung Calciphylaxis With Sodium Thiosulfate in a Patient With Sickle Cell Disease: A Case Report
por: Arrestier, Romain, et al.
Publicado: (2016)